Staphylococcus epidermidis

Revision as of 04:59, 22 April 2014 by Rossdonaldson1 (talk | contribs) (Rossdonaldson1 moved page Staph. epidermidis to Staphylococcus epidermidis)

Background

Antibiotic Sensitivities[1]

Organisms ' Staph. epidermidis
Penicillins Penicillin G 0
Penicillin V 0
Anti-Staphylocccal Penicillins Methicillin +
Nafcillin/Oxacillin +
Cloxacillin/Diclox. +
Amino-Penicillins AMP/Amox 0
Amox/Clav 0
AMP-Sulb 0
Anti-Pseudomonal Penicillins Ticarcillin +/-
Ticar-Clav +/-
Pip-Taxo +
Carbapenems Piperacillin 0
Doripenem +
Ertapenem +
Imipenem +
Meropenem +
Aztreonam 0
Fluroquinolones Ciprofloxacin +
Ofloxacin +
Pefloxacin +
Levofloxacin +
Moxifloxacin +
Gemifloxacin +
Gatifloxacin +
1st G Cephalosporin Cefazolin +/-
2nd G. Cephalosporin Cefotetan +/-
Cefoxitin +/-
Cefuroxime +/-
3rd/4th G. Cephalosporin CefoTAXime +/-
Cefizoxime +/-
CefTRIAXone +/-
Ceftobiprole +
Ceftaroline +
CefTAZidime +/-
Cefepime +/-
Oral 1st G. Cephalosporin Cefadroxil +/-
Cephalexin +/-
Oral 2nd G. Cephalosporin Cefaclor/Loracarbef +/-
Cefproxil +/-
Cefuroxime axetil +/-
Oral 3rd G. Cephalosporin Cefixime 0
Ceftibuten 0
Cefpodox/Cefdinir/Cefditoren +/-
Aminoglycosides Gentamicin +/-
Tobramycin +/-
Amikacin +/-
Chloramphenicol 0
Clindamycin 0
Macrolides Erythromycin +/-
Azithromycin 0
Clarithromycin 0
Ketolide Telithromycin 0
Tetracyclines Doxycycline 0
Minocycline 0
Glycylcycline Tigecycline +
Glyco/Lipoclycopeptides Vancomycin +
Teicoplanin +/-
Telavancin +
Fusidic Acid +
Trimethoprim +
TMP-SMX +/-
Urinary Agents Nitrofurantoin
Fosfomycin
Other Rifampin +
Metronidazole 0
Quinupristin dalfoppristin +
Linezolid +
Daptomycin +
Colistimethate 0

Key

  • S susceptible/sensitive (usually)
  • I intermediate (variably susceptible/resistant)
  • R resistant (or not effective clinically)
  • S+ synergistic with cell wall antibiotics
  • U sensitive for UTI only (non systemic infection)
  • X1 no data
  • X2 active in vitro, but not used clinically
  • X3 active in vitro, but not clinically effective for Group A strep pharyngitis or infections due to E. faecalis
  • X4 active in vitro, but not clinically effective for strep pneumonia

Table Overview

See Also

References

  1. Sanford Guide to Antimicrobial Therapy 2010